Sugi Predict

Sugi Predict / Compounds / SCHEMBL10024930

SCHEMBL10024930

SCHEMBL10024930

CC(C)c1ccc2cc(C(C)(C)C)ccc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 11/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ KCNH2 Q12809 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PDE2A O00408 2/20 0.36
▸ PDE10A Q9Y233 2/20 0.36
▸ AAK1 Q2M2I8 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ METAP2 P50579 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ PLA2G1B P04054 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14072394 0.87 SCN10A (0.37) SCN10AKCNH2MEN1KMT2APDE2A
SCHEMBL12388701 0.87 AAK1 (0.47) SCN10ABACE1MEN1KMT2APDE2A
SCHEMBL2609288 0.84 BACE1 (0.57) SCN10ABACE1PDE2APDE10AMETAP2
SCHEMBL15447134 0.76 PDE10A (0.39) SCN10AKCNH2PDE2APDE10AALDH1A1
SCHEMBL20047540 0.76 SCN10A (0.38) SCN10ABACE1KCNH2MEN1KMT2A
SCHEMBL23502416 0.76 PDE10A (0.39) SCN10AKCNH2PDE2APDE10AALDH1A1
SCHEMBL25494357 0.76 PDE2A (0.34) SCN10ABACE1KCNH2MEN1KMT2A
SCHEMBL2609300 0.76 HTR3A (0.46) BACE1MEN1KMT2APDE10AAAK1
SCHEMBL10182842 0.76 CYP1A2 (0.59) SCN10ABACE1KCNH2MEN1KMT2A
SCHEMBL2704185 0.76 KCNH2 (0.42) SCN10ABACE1KCNH2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220259225-A1 Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use REGENERON PHARMACEUTICALS, INC. 2022-08-18 — — US disclosed
US-20120039847-A1 Hepatitis C Virus Inhibitors ZHAO SHU-HAI (CN) 2012-02-16 — — US disclosed
US-7605176-B2 β-ketoamide compounds with MCH antagonistic activity BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-20 — — US disclosed
US-7592373-B2 Amide compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-22 — — US disclosed
US-20090069282-A1 ALKYNE COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120039847-A1 Hepatitis C Virus Inhibitors HAVCR2, HCCS, LIPC SCN10A 4632/4885BACE1 4203/4885KCNH2 4104/4885
US-20090069282-A1 ALKYNE COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS MCHR1, MCHR2, GPR119 SCN10A 3713/4885BACE1 3999/4885KCNH2 2632/4885
US-20220259225-A1 Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use SLC10A1, HNMT, OGFR SCN10A 4001/4885BACE1 2920/4885KCNH2 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.